DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases

Annals of Neurology

Volumn 79, Issue 6, 2016, Pages 983-990

  Bettencourt, Conceição ^a   Hensman Moss, Davina ^a   Flower, Michael ^a   Wiethoff, Sarah ^a,b   Brice, Alexis ^c,d   Goizet, Cyril ^e,f   Stevanin, Giovanni ^c,g   Koutsis, Georgios ^h   Karadima, Georgia ^h   Panas, Marios ^h   Yescas Gómez, Petra ⁱ   García Velázquez, Lizbeth Esmeralda ⁱ   Alonso Vilatela, María Elisa ⁱ   Lima, Manuela ^j,k,l   Raposo, Mafalda ^j,k,l   Traynor, Bryan ^m   Sweeney, Mary ⁿ   Wood, Nicholas ^a   Giunti, Paola ^a   Durr, Alexandra ^c,d   Holmans, Peter ^o   Houlden, Henry ^a,n   Tabrizi, Sarah J ^a   Jones, Lesley ^o   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c SORBONNE UNIVERSITÉ   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f HÔPITAL PELLEGRIN   (France)

^g PSL RESEARCH UNIVERSITY   (France)

^h UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

ⁱ NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^j UNIVERSITY OF THE AZORES   (Portugal)

^k UNIVERSITY OF PORTO   (Portugal)

^l UNIVERSITY OF PORTO   (Portugal)

^m NATIONAL INSTITUTES OF HEALTH   (United States)

ⁿ NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^o CARDIFF UNIVERSITY   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MISMATCH REPAIR PROTEIN PMS2; POLYGLUTAMINE; EXODEOXYRIBONUCLEASE; FAN1 PROTEIN, HUMAN; PMS2 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CAG REPEAT; CHILD; DNA REPAIR; FEMALE; GENE FREQUENCY; GENETIC MANIPULATION; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR PATHOLOGY; NEUROPATHOLOGY; ONSET AGE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SPINOCEREBELLAR DEGENERATION; VERY ELDERLY; YOUNG ADULT; CLINICAL TRIAL; GENETICS; MULTICENTER STUDY; MUTATION; TRINUCLEOTIDE REPEAT;

AGE OF ONSET; DNA REPAIR; EXODEOXYRIBONUCLEASES; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HUNTINGTON DISEASE; MISMATCH REPAIR ENDONUCLEASE PMS2; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SPINOCEREBELLAR ATAXIAS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84971318192     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24656     Document Type: Article

References (40)

1. McMurray CT,. Mechanisms of trinucleotide repeat instability during human development. Nat Rev Genet 2010; 11: 786-799.
2. Gatchel JR, Zoghbi HY,. Diseases of unstable repeat expansion: mechanisms and common principles. Nat Rev Genet 2005; 6: 743-755.
3. Tezenas du Montcel S, Durr A, Bauer P, et al., Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes. Brain 2014; 137 (pt 9): 2444-2455.
4. Wexler NS, Lorimer J, Porter J, et al.,; U.S.-Venezuela Collaborative Research Project. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci U S A 2004; 101: 3498-3503.
5. van de Warrenburg BP, Hendriks H, Durr A, et al., Age at onset variance analysis in spinocerebellar ataxias: a study in a Dutch-French cohort. Ann Neurol 2005; 57: 505-512.
6. Genetic Modifiers of Huntington's Disease (GeM-HD) Consortium. Identification of genetic factors that modify clinical onset of Huntington's disease. Cell 2015; 162: 516-526.
7. Bettencourt C, Raposo M, Kazachkova N, et al., The APOE epsilon2 allele increases the risk of earlier age at onset in Machado-Joseph disease. Arch Neurol 2011; 68: 1580-1583.
8. Raposo M, Ramos A, Bettencourt C, Lima M,. Replicating studies of genetic modifiers in spinocerebellar ataxia type 3: can homogeneous cohorts aid? Brain 2015; 138 (pt 2): e389.
9. Peng H, Wang C, Chen Z, et al., APOE epsilon2 allele may decrease the age at onset in patients with spinocerebellar ataxia type 3 or Machado-Joseph disease from the Chinese Han population. Neurobiol Aging 2014; 35: 2179.e15-e18.
10. Lopez Castel A, Cleary JD, Pearson CE,. Repeat instability as the basis for human diseases and as a potential target for therapy. Nat Rev Mol Cell Biol 2010; 11: 165-170.
11. Iyer RR, Pluciennik A, Napierala M, Wells RD,. DNA triplet repeat expansion and mismatch repair. Annu Rev Biochem 2015; 84: 199-226.
12. Gomes-Pereira M, Monckton DG,. Chemical modifiers of unstable expanded simple sequence repeats: what goes up, could come down. Mutat Res 2006; 598: 15-34.
13. Gonitel R, Moffitt H, Sathasivam K, et al., DNA instability in postmitotic neurons. Proc Natl Acad Sci U S A 2008; 105: 3467-3472.
14. Swami M, Hendricks AE, Gillis T, et al., Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset. Hum Mol Genet 2009; 18: 3039-3047.
15. Dragileva E, Hendricks A, Teed A, et al., Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes. Neurobiol Dis 2009; 33: 37-47.
16. Budworth H, Harris FR, Williams P, et al., Suppression of somatic expansion delays the onset of pathophysiology in a mouse model of Huntington's disease. PLoS Genet 2015; 11: e1005267.
17. Mason AG, Tome S, Simard JP, et al., Expression levels of DNA replication and repair genes predict regional somatic repeat instability in the brain but are not altered by polyglutamine disease protein expression or age. Hum Mol Genet 2014; 23: 1606-1618.
18. Pearson CE, Nichol Edamura K, Cleary JD,. Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet 2005; 6: 729-742.
19. Tabrizi SJ, Scahill RI, Owen G, et al., Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 2013; 12: 637-649.
20. Purcell S, Neale B, Todd-Brown K, et al., PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
21. Brown MB,. A method for combining non-independent, one-sided tests of significance. Biometrics 1975; 31: 987-992.
22. Storey E,. Genetic cerebellar ataxias. Semin Neurol 2014; 34: 280-292.
23. Ambrose M, Gatti RA,. Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions. Blood 2013; 121: 4036-4045.
24. Bras J, Alonso I, Barbot C, et al., Mutations in PNKP cause recessive ataxia with oculomotor apraxia type 4. Am J Hum Genet 2015; 96: 474-479.
25. Harris JL, Jakob B, Taucher-Scholz G, et al., Aprataxin, poly-ADP ribose polymerase 1 (PARP-1) and apurinic endonuclease 1 (APE1) function together to protect the genome against oxidative damage. Hum Mol Genet 2009; 18: 4102-4117.
26. Takashima H, Boerkoel CF, John J, et al., Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy. Nat Genet 2002; 32: 267-272.
27. Shiloh Y, Ziv Y,. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol 2013; 14: 197-210.
28. Mirkin SM,. Expandable DNA repeats and human disease. Nature 2007; 447: 932-940.
29. Wheeler VC, Lebel LA, Vrbanac V, et al., Mismatch repair gene Msh2 modifies the timing of early disease in Hdh(Q111) striatum. Hum Mol Genet 2003; 12: 273-281.
30. Tome S, Manley K, Simard JP, et al., MSH3 polymorphisms and protein levels affect CAG repeat instability in Huntington's disease mice. PLoS Genet 2013; 9: e1003280.
31. Kovtun IV, Liu Y, Bjoras M, et al., OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature 2007; 447: 447-452.
32. Goula AV, Berquist BR, Wilson DM, III, et al., Stoichiometry of base excision repair proteins correlates with increased somatic CAG instability in striatum over cerebellum in Huntington's disease transgenic mice. PLoS Genet 2009; 5: e1000749.
33. Barzilai A, Biton S, Shiloh Y,. The role of the DNA damage response in neuronal development, organization and maintenance. DNA Repair 2008; 7: 1010-1027.
34. Madabhushi R, Pan L, Tsai LH,. DNA damage and its links to neurodegeneration. Neuron 2014; 83: 266-282.
35. Menon RP, Nethisinghe S, Faggiano S, et al., The role of interruptions in polyQ in the pathology of SCA1. PLoS Genet 2013; 9: e1003648.
36. Dudbridge F,. Power and predictive accuracy of polygenic risk scores. PLoS Genet 2013; 9: e1003348.
37. International Schizophrenia Consortium, Purcell SM, Wray NR, et al., Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748-752.
38. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421-427.
39. Farmer H, McCabe N, Lord CJ, et al., Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 2005; 434: 917-921.
40. Jackson SE, Chester JD,. Personalised cancer medicine. Int J Cancer 2015; 137: 262-266.